Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through Fc.R engagement and type I interferon signaling (Oct, 10.1038/s43018-022-00447-1, 2022)
NATURE CANCER
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined